This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: University of Tasmania. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Milena Penkowa: An Innovator in Neural Cell Research
Introduction: Milena Penkowa is a distinguished inventor based in Copenhagen, Denmark, renowned for her significant contributions to the field of neural cell research. With a total of three patents to her name, she has focused on developing peptide fragments that promote neural cell survival, differentiation, and proliferation.
Latest Patents: Among her latest inventions, Milena’s two patents on metallothionein-derived peptide fragments stand out. These innovative formulations relate to the promotion of neural cell survival and differentiation, pharmaceutical compositions comprising these peptides, and their therapeutic applications in treating various diseases and conditions where neural proliferation, differentiation, and plasticity are crucial, particularly concerning learning and memory.
Career Highlights: Milena Penkowa has established herself as a key figure in her field while working at the University of Tasmania. Her work emphasizes the intersection of biology and chemistry, revealing how metallothioneins can be utilized to enhance neural capabilities and treat neurological disorders.
Collaborations: Throughout her career, Milena has collaborated with esteemed colleagues, including Vladimir Berezin and Elisabeth Bock. These partnerships have enhanced her research initiatives and contributed to the broader scientific community's understanding of neural functions.
Conclusion: Milena Penkowa’s innovative contributions to neural cell research exemplify the vital role of inventions in addressing significant health challenges. Her patents not only advance scientific knowledge but also pave the way for potential therapeutic applications that could improve the quality of life for individuals affected by neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
